Hisao Nishimura - Daicel Executive Officer, Senior Director of Research
DACHF Stock | USD 8.52 0.00 0.00% |
Director
Mr. Hisao Nishimura was serving as Managing Executive Officer, Chief Director of Research Development and Director in Daicel Corporation since June 2014. He joined the Company in August 1985. His previous titles include Executive Officer, Senior Director of Research and Manager of CPI Company in the Company. since 2014.
Age | 62 |
Tenure | 10 years |
Phone | 81 6 7639 7171 |
Web | https://www.daicel.com |
Daicel Management Efficiency
The company has return on total asset (ROA) of 0.0417 % which means that it generated a profit of $0.0417 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.137 %, meaning that it generated $0.137 on every $100 dollars invested by stockholders. Daicel's management efficiency ratios could be used to measure how well Daicel manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
De Shane | Avante Logixx | N/A | |
Per Aniansson | AAC Clyde Space | 52 | |
Elizabeth Tripp | Avante Logixx | N/A | |
Carol Osler | Avante Logixx | N/A | |
Claude Boulay | Corby Spirit and | 51 | |
Robert Llewellyn | Corby Spirit and | 72 | |
Paul Duffy | Corby Spirit and | N/A | |
Joseph Leeder | Avante Logixx | N/A | |
Andrew Coles | Avante Logixx | 48 | |
Emmanuel Mounouchos | Avante Logixx | 60 | |
Bruce Bronfman | Avante Logixx | N/A | |
Donald Lussier | Corby Spirit and | 66 | |
Per Danielsson | AAC Clyde Space | 53 | |
Patricia Nielsen | Corby Spirit and | 58 | |
Stewart Lyons | Avante Logixx | N/A | |
Anita Bernie | AAC Clyde Space | N/A | |
Thierry Pourchet | Corby Spirit and | 48 | |
Kate Thompson | Corby Spirit and | N/A | |
Philippe Dreano | Corby Spirit and | 56 | |
William Whitehorn | AAC Clyde Space | 56 |
Management Performance
Return On Equity | 0.14 | |||
Return On Asset | 0.0417 |
Daicel Leadership Team
Elected by the shareholders, the Daicel's board of directors comprises two types of representatives: Daicel inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Daicel. The board's role is to monitor Daicel's management team and ensure that shareholders' interests are well served. Daicel's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Daicel's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tetsuzo Miyazaki, Sr. Managing Executive Officer | ||
Dieter Heckmann, Executive Officer and Presidentident of Subsidiaries | ||
Chiyoko Shimozaki, Independent Director | ||
Yoshimi Ogawa, Executive Officer, Manager of Production Technology Office, Director | ||
Satoshi Sakamoto, Executive Officer, Manager of Specialized Machinery MSD Company, Director of Specialized Machinery MSD Company MSD Business and Presidentident of Subsidiary | ||
Hisanori Imanaka, Executive Officer, Manager of Raw Material Center | ||
Yukio Yoshino, Executive Officer and Presidentident of Subsidiary | ||
Teisuke Kitayama, Independent Director | ||
Naohide Hakushi, Executive Officer, Ohtake Plant Manager | ||
Haruyoshi Tashika, Executive Officer, Senior Manager of Production in Organic Synthesis Company, Assistant Manager of Organic Synthesis Company | ||
Tetsumasa Nonaka, Executive Officer, Manager of Quality Audit Office, Assistant Manager of Responsible Care Office | ||
Yasuhiro Sakaki, Executive Officer, Manager of Organic Synthesis Company | ||
Akio Kojima, Executive Officer, Manager of Cellulose Company | ||
Hitoshi Hayashi, Executive Officer, Manager of Organic Chemical Products Company, Chief Director of Marketing in Organic Chemical Products Company | ||
Shinji Fujita, Leader of Accounting Group in Business Support Center, Assistant Manager of Business Support Center | ||
Hisao Nishimura, Executive Officer, Senior Director of Research | ||
Tadao Kondo, Independent Director | ||
Koichi Maruyama, Executive Officer and Presidentident of Subsidiary | ||
Takahiko Ando, Executive Office, Manager of Himeji Production Center, Aboshi Plant Manager | ||
Yasunori Iwai, Executive Officer, Director of General Research Institute, Director of Corporate Research Institute in Research Supervision Unit | ||
Takashi Ueno, Executive Officer, Arai Plant Manager and Presidentident of Subsidiary | ||
Misao Fudaba, CEO and President Director, Chairman of Management Advisory Committee and Member of Nomination and Compensation Committee | ||
Kotaro Sugimoto, Executive Officer, Representative Director and President of Subsidiary | ||
Naotaka Kawaguchi, Executive Officer, Assistant Manager of Aerospace & Defense Systems/Safety Systems Company, Harima Plant Manager in Aerospace & Defense Systems/Safety Systems Company | ||
Masumi Fukuda, Sr. Managing Executive Officer, General Manager of Corporate Support Center, Director and President of Daicel Fin. Ltd | ||
Akihisa Takabe, Executive Officer, Deputy Chief Director of Research & Development | ||
Kunie Okamoto, Independent Director | ||
Hidekage Kojima, Executive Officer, Manager of General Planning Office | ||
Yuji Iguchi, Managing Executive Officer, Senior Manager of Topas Business Office | ||
Ikuo Takahashi, Executive Officer, Manager of Innovation Park Center, Manager of Corporate Research Center in Main Research & Development Unit | ||
Masaaki Fujio, Executive Officer, Kanzaki Plant Manager | ||
Masahiko Hirokawa, Leader of IR Public Relations Group in Business Support Center | ||
Takashi Iiyama, Executive Officer, Vice President of Organic Chemical Products Company, Manager of Process Development Center in Organic Chemical Products Company | ||
Masayuki Mune, Managing Executive Officer | ||
Masafumi Nogimori, Independent Director | ||
Yasuo Tsuji, Executive Officer, Ohtake Plant Manager | ||
Akishige Okada, Independent Director | ||
Tetsuaki Nonaka, Executive Officer, Manager of Quality Management Office | ||
Mikio Yagi, Executive Officer, Assistant Manager of Aerospace & Defense Systems/Safety Systems Company, Director of Aerospace & Defense Systems in Aerospace & Defense Systems/Safety Systems Company | ||
Noboru Goto, Director and President of Polyplastics Co Ltd |
Daicel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Daicel a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.14 | |||
Return On Asset | 0.0417 | |||
Profit Margin | 0.07 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 3.6 B | |||
Shares Outstanding | 291.55 M | |||
Shares Owned By Insiders | 5.30 % | |||
Shares Owned By Institutions | 57.27 % | |||
Price To Earning | 17.64 X | |||
Price To Book | 0.90 X |
Pair Trading with Daicel
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Daicel position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daicel will appreciate offsetting losses from the drop in the long position's value.Moving together with Daicel Pink Sheet
0.69 | GOOG | Alphabet Class C Earnings Call This Week | PairCorr |
Moving against Daicel Pink Sheet
0.83 | MCD | McDonalds Report 23rd of April 2024 | PairCorr |
0.73 | INTC | Intel Earnings Call This Week | PairCorr |
0.72 | BA | Boeing Earnings Call This Week | PairCorr |
0.59 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
0.55 | AAPL | Apple Inc Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Daicel could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Daicel when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Daicel - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Daicel to buy it.
The correlation of Daicel is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Daicel moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Daicel moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Daicel can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Daicel. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Daicel information on this page should be used as a complementary analysis to other Daicel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Daicel Pink Sheet analysis
When running Daicel's price analysis, check to measure Daicel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daicel is operating at the current time. Most of Daicel's value examination focuses on studying past and present price action to predict the probability of Daicel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daicel's price. Additionally, you may evaluate how the addition of Daicel to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |